Skip to main content
Tong Ren Tang Technologies Co. Ltd. logo

Tong Ren Tang Technologies Co. Ltd. — Investor Relations & Filings

Ticker · 1666 ISIN · CNE100000585 HKEX Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2026-03-27 Earnings Release
Country HK Hong Kong
Listing HKEX 1666

About Tong Ren Tang Technologies Co. Ltd.

http://www.tongrentangkj.com

Tong Ren Tang Technologies Co. Ltd. is a leading enterprise specializing in the production and distribution of traditional Chinese medicine (TCM). Originating from the Tong Ren Tang brand established in 1669, the company holds a distinguished heritage, including a history of supplying Chinese medicine to the royal families for 188 years. The core business encompasses the manufacturing and sale of diverse pharmaceutical products, such as Chinese patent medicines, herbal medicines, biological preparations, and antibiotics. Operating across Mainland China and Hong Kong, the company leverages its recognized brand and historical expertise while integrating modern technology to advance the development and global reach of TCM.

Recent filings

Filing Released Lang Actions
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Earnings Release Classification · 88% confidence The document is titled “Annual Results Announcement for the Year Ended 31 December 2025” and contains a Chairman’s statement, results highlights, consolidated financial statements and notes. It is a preliminary announcement of the year’s financial performance rather than a full statutory annual report or a quarterly interim report. This fits the definition of an Earnings Release (initial announcement of periodical financial results). FY 2025
2026-03-27 English
ANNOUNCEMENT ON RESULTS OF SUBSIDIARY
Earnings Release Classification · 95% confidence The document is an announcement by Tong Ren Tang Technologies Co. Ltd. regarding the financial results of its subsidiary, Tong Ren Tang Chinese Medicine. It provides key financial statements (Profit or Loss, Comprehensive Income, and Financial Position) for the year ended 31 December 2025. While it contains financial data, it is an initial announcement of results rather than a full Annual Report (10-K) or a standalone Audit Report. It fits the definition of an Earnings Release (ER) as it provides the key highlights of financial performance for a specific period. FY 2025
2026-03-20 English
NOTICE OF BOARD MEETING
Report Publication Announcement Classification · 100% confidence The document is a 'Notice of Board Meeting' issued by Tong Ren Tang Technologies Co. Ltd. It announces that a board meeting will be held on 27 March 2026 to approve the audited results for the year ended 31 December 2025. This is a standard announcement regarding the upcoming publication of financial results and is not the financial report itself. According to the 'Menu vs Meal' rule, an announcement regarding the timing or release of a report is classified as a Report Publication Announcement (RPA).
2026-03-16 English
Monthly Return for the month ended 28 February 2026
Share Issue/Capital Change Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and public float. As it is a recurring regulatory filing regarding share capital and listing compliance that does not fit into specific categories like 'Share Issue' (which is for specific events) or 'Annual Report', it falls under the 'Regulatory Filings' category.
2026-03-02 English
RENEWAL OF CONTINUING CONNECTED TRANSACTIONS ADVERTISING AGENCY FRAMEWORK AGREEMENT
Regulatory Filings Classification · 98% confidence The document is an official announcement from a Hong Kong-listed company regarding the 'Renewal of Continuing Connected Transactions' and an 'Advertising Agency Framework Agreement'. It details the terms, pricing policies, historical caps, and proposed future caps for these transactions. This type of disclosure is a standard regulatory requirement for listed companies in Hong Kong (HKEX) to inform shareholders about transactions with connected parties. Since it is a specific regulatory disclosure regarding business operations and compliance rather than a financial report, an earnings release, or a simple report publication notice, it falls under the 'Regulatory Filings' category.
2026-02-26 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 98% confidence The document is titled 'LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS' and provides a detailed breakdown of the board members, their classifications (Executive, Non-Executive, Independent, Employee), and their committee assignments. This is a standard corporate governance disclosure regarding board composition, which falls under the 'DIRS' category for director-related information or 'CGR' for governance. Given the specific focus on the list of directors and their roles, 'DIRS' is the most appropriate classification for director-related disclosures.
2026-02-06 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.